If this case includes the installation of a second agent on the VM, a local Aggregator agent will be updated, to accept / collect events from this new agent as well.
Since long term Denosumab therapy is generally well tolerated, introduction of Denosumab as a second agent for the inhibition of osteoclast activity, may further deprive tumor cells of growth factors sequestered in the bone matrix.
The second schedule consisted of inverting the order of exposure of the cells to the different agents, and the third schedule was the simultaneous addition of sapacitabine and a second agent for a period of 48 h.
Two recent reports showed an approximate A1C reduction of 1.0% with the addition of a second agent to metformin (19, 20), and the addition of a third agent causes a further reduction of 0.64 0.97% (21).
Current approaches that show potential include the addition of a third agent to combination chemotherapy, and the substitution of platinum agents by nonplatinum alternatives in taxane-based doublets.
Options include the direct addition of a third agent to a doublet, resulting in a three-drug combination, or the administration of sequential regimens.
Addition of a third agent to platinum-based doublet may be an option to improve outcomes in NSCLC.
However, this maintenance strategy appears to be more effective compared with the addition of a third agent to the conventional platinum doublet.
According to previous results, also in our trial the addition of a third agent to doublet therapy showed no survival benefit (Delbaldo et al, 2004).
An angiogenic inhibitor that recognises and binds to VEGF is bevacizumab, a monoclonal antibody which was the first agent of its kind to slow tumor growth in glioblastoma, nonsmall cell lung cancer, and metastatic colorectal cancer patients [ 46].
